Hundreds of adults and teenagers in England with a rare, inherited eye disease will benefit from a new treatment after NICE today recommended idebenone for visual impairment caused by Leber's ...

NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.

The treatment combines pembrolizumab, made by Merck Sharp & Dohme, with chemotherapy drugs carboplatin and paclitaxel. Pembrolizumab is an immunotherapy that helps the immune system recognise and ...

About shared decision making Shared decision making is a joint process in which a healthcare professional works together with a person to reach a decision about care.

This quality standard covers prevention, behavioural management, assessment, and treatment of overweight, obesity and central adiposity in children and young people aged over 2 years, and adults. This ...

People with a learning disability are at greater risk of obesity than the general population and may need tailored support to access services that can help them achieve or maintain a healthy lifestyle ...

What the quality statement means for different audiences Service providers (specialist overweight and obesity management services, primary care) ensure that protocols are in place for providing ...

What the quality statement means for different audiences Service providers (such as primary care services and secondary care services) ensure that children and young people can have their BMI recorded ...

About NICE guidelines NICE guidelines are evidence-based recommendations for health and care in England and Wales. They help health and social care professionals to prevent ill health, promote good ...

Chair Paul Lincoln, independent consultant. Core members Ian Basnett, public health director, Barts Health NHS Trust. Sally Cartwright, public health consultant, Luton Council. Rachel Chapman, public ...

Cost comparison suitability is determined during scoping. See the scope section of the Health Technology Evaluation manual for more information. We started using this process in April 2023. We ask ...

Technology appraisals and highly specialised technologies charging timeline A timeline showing where in the evaluation process companies will be charged.